Fexofenadine
| Fexofenadine | |
|---|---|
| Salts [] | |
|---|---|
| Fexofenadine hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 501.70 g/mol [1] |
| Appearance | Crystals from methanol-butanone [1] |
| Melting point | 142.5 °C [1] |
| Solubility | Slightly soluble [1] |
| Predicted LogP | 3 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C32H39NO4 |
| IUPAC name | 2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid |
| SMILES | CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O |
| InChI | InChI=1S/C32H39NO4/c1-31(2,30(35)36)25-17-15-24(16-18-25)29(34)14-9-21-33-22-19-28(20-23-33)32(37,26-10-5-3-6-11-26)27-12-7-4-8-13-27/h3-8,10-13,15-18,28-29,34,37H,9,14,19-23H2,1-2H3,(H,35,36) |
| InChIKey | RWTNPBWLLIMQHL-UHFFFAOYSA-N |
| CAS number | 83799-24-0 |
| UNII | E6582LOH6V |
| PubChem CID | 3348 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 14.4 hours |
| Metabolism | Hepatic (≤5% of dose) |
| Excretion | Feces (~80%) and urine (~10%) as unchanged drug |
| Routes of administration | By mouth |
Fexofenadine (also known as Carboxyterfenadine, Terfenadine carboxylate, Terfenadine-COOH, Terfenadine acid metabolite, Telfast, Mdl 16455, Fexofenadina, Mdl-16455, fexofenadinum or R06ax26) is a substance of the carboxylic acid class.
Chemistry
Salts []
Stereochemistry []
Fexofenadine is a racemic mixture of the enantiomers (optical activity ( + / - )).
Druglikeness
Lipinski's rule of five
Fexofenadine matches Lipinski's rule of five (violations: 1).Pharmacology
ATC Classification
- respiratory system (R)
- antihistamines for systemic use (R06)
- antihistamines for systemic use (R06A)
- other antihistamines for systemic use (R06AX)
- fexofenadine (R06AX26)
MeSH Classification
Mechanism of action []
The H<sub>1</sub> histamine receptor is responsible for mediating hypersensitivity and allergic reactions. Exposure to an allergen results in degranulation of mast cells and basophils, which then release histamine and other inflammatory mediators. Histamine binds to, and activates, H<sub>1</sub> receptors, which results in the further release of pro-inflammatory cytokines, such as interleukins, from basophils and mast cells. These downstream effects of histamine binding are responsible for a wide variety of allergic symptoms, such as pruritus, rhinorrhea, and watery eyes. Fexofenadine is considered an “inverse agonist” of the H<sub>1</sub> receptor because it binds to and stabilizes the inactive form of the receptor, preventing its activation and subsequent downstream effects. It has a potent and selective affinity for H<sub>1</sub> receptors, and there is no evidence that it carries antidopaminergic, antiserotonergic, anticholinergic, sedative, or adrenergic blocking activity. Fexofenadine does not cross the blood-brain barrier and thus is unlikely to cause significant CNS effects. [1]
Interactions []
Medical side effects []
61 side effects listed on drug labels in SIDER 4.1 (fexofenadine).
- Vomiting
- Headache
- Cough
- Diarrhoea
- Upper respiratory tract infection
- Injury
- Myalgia
- Musculoskeletal discomfort
- Back pain
- Viral infection
- Body temperature increased
- Nasopharyngitis
- Rhinorrhoea
- Otitis media
- Pain
- Dizziness
- Pain in extremity
- Abdominal discomfort
- Dyspepsia
- Dysmenorrhoea
- Nausea
- Somnolence
- Asthenia
- Fatigue
- Abdominal pain
- Gastrointestinal pain
- Dry eye
- Epistaxis
- Anaphylactic shock
- Angioedema
- Dyspnoea
- Dermatitis
- Rash
- Flushing
- Hypersensitivity
- Nervousness
- Tension
- Nightmare
- Pruritus
- Urticaria
- Chest discomfort
- Sleep disorder
- Insomnia
- Atrial fibrillation
- Infection
- Ear pain
- Flatulence
- Cardiac failure congestive
- Palpitations
- Rhinitis perennial
- Sinusitis
- Tachycardia
- Thirst
- Pollakiuria
- Dry mouth
- Agitation
- Increased appetite
- Vision blurred
- Throat irritation
- Psychotic disorder
- Paranoia
Indications
- Chronic spontaneous urticaria
- Eye redness
- Lacrimation
- Perennial allergic rhinitis
- Pruritus
- Rhinitis allergic
- Rhinorrhoea
- Seasonal allergy
- Sedation
- Sneezing
- Urticaria
- Welts
Subjective effects []
| 0xea / Fexofenadine [] | |
|---|---|
Routes:
| |
Legal status []
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 3348, Fexofenadine. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/3348
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Fexofenadine. UNII: E6582LOH6V. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/E6582LOH6V
Telfast 30mg Film-coated Tablets - Summary of Product Characteristics (SmPC). (emc). 25 October 2019. https://www.medicines.org.uk/emc/product/5529/smpc
Almerg 180 mg Film-Coated Tablets - Summary of Product Characteristics (SmPC). (emc). https://www.medicines.org.uk/emc/product/10147/smpc
Fexofenadine Hydrochloride 120 mg Film-Coated Tablets - Summary of Product Characteristics (SmPC). (emc). 22 March 2021. https://www.medicines.org.uk/emc/product/10144/smpc
Allegra (fexofenadine hydrochloride) tablet, orally disintegrating for oral use Allegra (fexofenadine hydrochloride) tablet, film coated for oral use Allegra (fexofenadine hydrochloride) suspension for oral useInitial U.S. Approval: 1996. DailyMed. 15 December 2008. https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=17669
Allegra Allergy- fexofenadine hydrochloride tablet, coated. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f061d6b1-89f7-4d5f-ac59-9c73408517c1
ALLEGRA (fexofenadine hydrochloride) Product Monograph. Sanofi Consumer Health Inc. 7 November 2019. http://products.sanofi.ca/en/allegra.pdf
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 10:32:13 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 10:32:09 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 10:32:09 |
| gsrs | ok | 2026-11-20 10:32:09 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0005030) | 2026-11-20 10:32:09 |
| kegg | ok | 2026-11-20 10:32:11 |
| pubchem | ok | 2026-11-20 10:32:07 |
| missing (no r/tripreports posts mention it) | 2026-11-20 10:32:09 | |
| sider | ok | 2026-11-20 10:32:09 |
| structure | ok | 2026-11-20 10:32:09 |
| wikipedia | ok | 2026-11-20 10:32:09 |